Circulating Extracellular Vesicles: An Effective Biomarker for Cancer Progression

被引:1
|
作者
Chatterjee, Madhura [1 ]
Gupta, Saurabh [2 ]
Nag, Sayoni [3 ]
Rehman, Ishita [4 ]
Parashar, Deepak [5 ]
Maitra, Arindam [1 ]
Das, Kaushik [1 ]
机构
[1] Natl Inst Biomed Genom, Biotechnol Res & Innovat Council, Kalyani 741251, India
[2] GLA Univ, Dept Biotechnol, Mathura 281406, India
[3] Brainware Univ, Dept Biotechnol, Barasat 700125, India
[4] Neotia Univ, Dept Biotechnol, Parganas 743368, India
[5] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Milwaukee, WI 53226 USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2024年 / 29卷 / 11期
关键词
biomarkers; cancer biomarkers; circulating extracellular vesicles; clinical trials; extracellular vesicles; therapeutics; POTENTIAL DIAGNOSTIC BIOMARKERS; EXOSOME-MEDIATED TRANSFER; INTERCELLULAR COMMUNICATION; CELLS PROMOTES; MESSENGER-RNA; PROGNOSTIC BIOMARKER; SERUM EXOSOMES; MICROVESICLES; EXPRESSION; MECHANISM;
D O I
10.31083/j.fbl2911375
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extracellular vesicles (EVs), the ubiquitous part of human biology, represent a small heterogenous, membrane-enclosed body that contains a diverse payload including genetic materials in the form of DNA, RNAs, small non-coding RNAs, etc. mostly mirroring their source of origin. Since, a vast majority of research has been conducted on how nucleic acids, proteins, lipids, and metabolites, associated with EVs can be effectively utilized to identify disease progression and therapeutic responses in cancer patients, EVs are increasingly being touted as valuable and reliable identifiers of cancer biomarkers in liquid biopsies. However, the lack of comprehensive clinical validation and effective standardization protocols severely limits its applications beyond the laboratories. The present review focuses on understanding the role of circulating EVs in different cancers and how they could potentially be treated as cancer biomarkers, typically due to the presence of bioactive molecules such as small non-coding RNAs, RNAs, DNA, proteins, etc., and their utilization for fine-tuning therapies. Here, we provide a brief general biology of EVs including their classification and subsequently discuss the source of circulatory EVs, the role of their associated payload as biomarkers, and how different cancers affect the level of circulatory EVs population.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Potential of Circulating Extracellular Vesicles as a Biomarker for Breast Cancer
    Moloney, B. M.
    Gilligan, K.
    Joyce, D. J.
    Kerin, M. J.
    Dwyer, R. M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S327 - S327
  • [2] Exploring the biomarker potential of circulating small extracellular vesicles in pancreatic cancer
    Panda, Arunima
    Casari, Ilaria
    Halder, Abir
    Abu Shawish, Walid
    Greening, David
    Dye, Danielle
    Ragunath, Krish
    Falasca, Marco
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 34 - 35
  • [3] Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy
    Zhou, E.
    Li, Yumei
    Wu, Feng
    Guo, Mengfei
    Xu, Juanjuan
    Wang, Sufei
    Tan, Qi
    Ma, Pei
    Song, Siwei
    Jin, Yang
    EBIOMEDICINE, 2021, 67
  • [4] Extracellular vesicles in cancer progression
    Ortiz, Angelica
    SEMINARS IN CANCER BIOLOGY, 2021, 76 : 139 - 142
  • [5] Circulating extracellular vesicles as treatment response biomarker in multiple sclerosis
    TorresIglesias, G.
    Gutierrez-Fernandez, M.
    Piniella-Alcalde, D.
    Fernandez-Fournier, M.
    Munoz, I. Puertas
    Gomez-de Frutos, M.
    Chamorro, B.
    Tallonbarranco, A.
    Diez-Tejedor, E.
    Otero-Ortega, L.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2022, 42 (1_SUPPL): : 147 - 148
  • [6] A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer
    Bockorny, Bruno
    Muthuswamy, Lakshmi
    Huang, Ling
    Hadisurya, Marco
    Lim, Christine Maria
    Tsai, Leo L.
    Gill, Ritu R.
    Wei, Jesse L.
    Bullock, Andrea J.
    Grossman, Joseph E.
    Besaw, Robert J.
    Narasimhan, Supraja
    Tao, Weiguo Andy
    Perea, Sofia
    Sawhney, Mandeep S.
    Freedman, Steven D.
    Hildago, Manuel
    Iliuk, Anton
    Muthuswamy, Senthil K.
    ELIFE, 2024, 12
  • [7] Circulating Extracellular Vesicles in Cancer Diagnosis and Monitoring
    Choi, Dong-Sic
    Lee, Jaewook
    Go, Gyeongyun
    Kim, Yoon-Keun
    Gho, Yong Song
    MOLECULAR DIAGNOSIS & THERAPY, 2013, 17 (05) : 265 - 271
  • [8] Circulating extracellular vesicles as biomarker for diagnosis, prognosis, and monitoring in glioblastoma patients
    Ricklefs, Franz L.
    Wollmann, Kathrin
    Salviano-Silva, Amanda
    Drexler, Richard
    Maire, Cecile L.
    Kaul, Michael G.
    Reimer, Rudolph
    Schueller, Ulrich
    Heinemann, Sarina
    Kolbe, Katharina
    Mummert, Tobias
    Glatzel, Markus
    Peine, Sven
    Gempt, Jens
    Westphal, Manfred
    Duehrsen, Lasse
    Lamszus, Katrin
    NEURO-ONCOLOGY, 2024, 26 (07) : 1280 - 1291
  • [9] Extracellular vesicles: important collaborators in cancer progression
    Sato, Shinya
    Weaver, Alissa M.
    EXTRACELLULAR VESICLES AND MECHANISMS OF CELL-CELL COMMUNICATION, 2018, 62 (02): : 149 - 163
  • [10] Extracellular vesicles in cancer progression: mechanisms and significance
    Gao, Ying
    Wei, Denghui
    Zhong, Li
    Liao, Dan
    Zheng, Xueping
    Lin, Yujie
    Fang, Dongmei
    Chang, Boyang
    Kang, Tiebang
    SCIENCE CHINA-LIFE SCIENCES, 2025,